We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Hematology Analyzers Measure Increased Eosinophil Count Associated with Subprophylactic Anticoagulation in COVID-19 Patients

By LabMedica International staff writers
Posted on 26 Apr 2021
Mindray (Shenzhen, China) hematology analyzers are using advanced technologies to detect increased eosinophil count that is associated with the level of subprophylactic anticoagulation in COVID-19 patients.

Is prophylactic anticoagulant therapy a common treatment for clinicians to deal with thrombotic events in COVID-19? More...
Is there a connection between the eosinophil count and anticoagulation monitoring in COVID-19 patients? Thrombosis has emerged as an important complication among hospitalized patients with COVID-19. A prothrombotic state induced by SARS-Cov-2 can manifest in venous thromboembolism (VTE), arterial thrombosis and disseminated intravenous coagulation (DIC). In 28 studies including 2928 patients, thrombotic complications occurred in 34% of ICU patients, deep venous thrombosis (DVT) reported in 16.1% and pulmonary embolism in 12.6% of patients, and were associated with high mortality.

Low molecular weight heparin (LMWH) and unfractionated heparin (UFH) are recommended by the international society for thrombosis on hemostasis (ISTH), American Society of Hematology (ASH) for the treatment of thrombotic events associated with SARS-CoV-2 infection. Particularly, LMWH has a stronger antithrombotic effect than UFH. LMWH predominantly acts on factor Xa. For this reason, LMWH activity is monitored using serum anti-factor Xa activity (AFXa) levels instead of activated Partial Thromboplastin Time (aPTT). Enoxaparin is one of the most important LMWH. The AFXa level reached peak 3-5 hours after administration. The AFXa levels below 0.2 IU/mL may increase the risk of VTE in COVID-19 patients, due to the hypercoagulability.

Dr. Selma Ari has found the increased eosinophil count is associated with the level of subprophylactic anticoagulation in COVID-19 patients. In the laboratory results, only eosinophil counts and AFXa are significantly different between subprophylactic anticoagulation group and prophylactic anticoagulation group when the patients are admitted to hospital. Laboratory analysis collected before the discharge of patients revealed that eosinophil counts in subprophylactic anticoagulation group were higher than in prophylactic anticoagulation group , whereas AFXa were lower in subprophylactic anticoagulation group. Eosinophil induces platelet aggregation and thrombus formation through the production of major basic protein (MBP) and eosinophil peroxidase (EPX). Enzymes released from eosinophils (peroxidases, cationic proteins, and neurotoxins) may decrease the anticoagulant activity of heparin.

In this study, in subprophylactic anticoagulation group, high eosinophil levels had lower anticoagulant activity in COVID-19 patients. Eosinophil counts were examined with Mindray BC- 6800 auto hematology analyzer. Its SF Cube analysis technology can produce three-dimensional scattergram which can help doctors better identify and differentiate blood cell populations, especially to reveal abnormal cell population undetected by other techniques. Nowadays a large number of parameters on BC-6800 can be used in clinical diagnosis and scientific research. Therefore, clinicians are welcome to do more research on COVID-19 on Mindray BC-6200/BC-6800/BC-6800Plus/ CAL 6000/CAL 8000.




Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.